Showing 261-270 of 333 grants

Title Institution Researcher Program Duration Total Award Amount
A smart Semiconductor based Continuous Diabetes Monitoring Platform Integrated Medical Sensors Inc Muhammad Mujeeb-U-Rahman Improving Lives 01-June-2022 to 31-May-2025 $500,000.00
ROLE OF ZBED3 IN BETA CELL STRESS RESPONSE AND VULNERABILITY AGAINST AUTOIMMUNITY Indiana Biosciences Research Institute Erica Cai Cures 01-March-2023 to 29-February-2028 $999,737.71
Targeting ER cargo proteins for beta cell protection against cellular stress and autoimmunity Indiana Biosciences Research Institute Erica Cai Cures 01-September-2023 to 31-August-2026 $499,934.12
Genome-scale CRISPR screens identify ER export cargo proteins as mediators for β-cell stress response and antigen presentation Indiana Biosciences Research Institute Isabela Lovizutto Iessi Longo Cures 01-March-2023 to 28-February-2026 $135,307.11
Exploiting SDF2L1 to protect against beta cell death and dysfunction in T1D Indiana Biosciences Research Institute Michael Kalwat Cures 01-December-2024 to 30-November-2027 $748,169.00
Mitigating Diabetic Ketoacidosis Risk in Adjunctive Therapy (MDKARAT) Illinois Institute of Technology Mudassir Rashid Improving Lives 01-April-2022 to 31-March-2025 $255,709.80
Bringing Beta Cell Regenerative Therapy to the Clinic Icahn School of Medicine at Mount Sinai Andrew Stewart Cures 01-January-2024 to 31-December-2026 $1,000,000.00
The KQ1 serum study: amendment & extension Icahn School of Medicine at Mount Sinai Dirk Homann Cures 01-November-2024 to 31-October-2027 $1,873,290.24
Towards an integrated proteomic and transcriptomic single-cell atlas of the human pancreas Icahn School of Medicine at Mount Sinai Dirk Homann Cures 01-June-2024 to 31-May-2026 $145,989.21
Exploring the Effects of Beta Cell Regenerative Drugs on Cell Fate Decisions in Human Pancreatic Islets Icahn School of Medicine at Mount Sinai Esra Karakose Cures 01-March-2025 to 28-February-2030 $999,999.00